| Literature DB >> 30890039 |
Carol Vlassoff1, Ronald St John2.
Abstract
BACKGROUND: The right to health was enshrined in the constitution of the World Health Organization (WHO) in 1946 and in the Universal Declaration of Human Rights in 1948. The latter Declaration, which also guaranteed women's rights, was signed by almost all countries in the world. Subsequent international conventions reinforced these rights, requiring that women be able to realize their fundamental freedoms and dignity. Although the value of incorporating gender into health systems has been increasingly acknowledged over the years, gender inequalities in health persist.Entities:
Keywords: Gender and Health Inequality; Gender equality; Latin America and Caribbean; Zika virus; health systems building blocks; human rights
Mesh:
Year: 2019 PMID: 30890039 PMCID: PMC6427496 DOI: 10.1080/16549716.2019.1570645
Source DB: PubMed Journal: Glob Health Action ISSN: 1654-9880 Impact factor: 2.640
Figure 1.The reciprocal relationship between the duty bearer and rights holders.6
Details of the sources reviewed.
| Main search term(s) | Number searched | Number selected/reviewed | Key documents |
|---|---|---|---|
| Gender inequality in health | 84 | 51 | Muralidharan et al. [ |
| Gender and health systems | 22 | 12 | Percival et al. [ |
| Gender and primary health care | 10 | 7 | WHO ( |
| Gender and human rights | 80 | 45 | Nordic Trust Fund and World Bank (2013) Report of gender and human rights-based approaches in development |
| Gender, health, and human rights | 13 | 7 | WHO [ |
| Human rights | 8 | 5 | United Nations Development Group (2003) The human rights based approach to development cooperation towards a common understanding among UN agencies |
| Right to health | 15 | 12 | Office of the High Commissioner for Human Rights [ |
| ZIKV general | 14 | 8 | Centers for Disease Control and Prevention (n.d.) Clinical guidance for healthcare providers for prevention of sexual transmission of Zika virus |
| ZIKV, gender, and human rights | 31 | 17 | Pan American Health Organization. ZIKA ethics consultation: ethics guidance on key issues raised by the outbreak. 6–7 April 2015 |
| Frameworks | 14 | 5 | WHO [ |
(a) Framework (Part 1) to assess gender-related health systems’ obligations vis-à-vis ZIKV.
| Gender-related programmatic obligations | ||||
|---|---|---|---|---|
| Prevention | Care and treatment | |||
| Health system (duty bearer) perspective | Pregnancy and childbirth | Sexual transmission | Counselling | CZS and autoimmune neurological conditions |
| 1. Leadership and governance | -Policies ensuring women’s and partners’ access to relevant reproductive health | -Policies ensuring access to protective options for at-risk sexually active people | -Policies ensuring women’s and partners’ access to confidential RH counselling | -Policies for appropriate, gender and culturally sensitive treatment (Rx) and care |
| -Oversight mechanisms exist, with community input | -Relevant oversight mechanisms exist | -Policies ensuring access of at-risk sexually active people to gender and culturally sensitive confidential counselling | -Oversight mechanisms exist | |
| -Oversight mechanisms exist | ||||
| Obligation met (yes/no, comment) | ||||
| 2. Health financing | -Affordable reproductive insecticide treated nets (ITNs) provided | -Access to safe and affordable contraceptive methods | -Affordable, confidential, gender and culturally sensitive counselling services provided by health system | -Comprehensive and high-quality care and Rx provided free of cost to those in need |
| Obligation met (yes/no, comment) | ||||
| 3. Health workforce | -Health workers trained in appropriate prevention measures | Health workers trained in range of appropriate contraceptive methods | Counsellors trained in ZIKV prevention and related gender and cultural issues | Health workers trained in gender and culturally sensitive care and Rx |
| Obligation met (yes/no, comment) | ||||
| 4. Health services | -Timely screening and diagnosis of asymptomatic pregnant women, testing for symptomatic pregnant women and testing for infants with possible CZV implemented in gender and culturally sensitive way | Guidelines implemented in gender and culturally sensitive way | -ANC counselling integrates information with HIV, malaria, dengue, as appropriate | Comprehensive and high-quality care and Rx, including abortion, provided in gender and culturally sensitive way |
| Obligation met (yes/no, comment) | ||||
| 5. Medical products | -ITNs and appropriate insecticides available | -Adequate supply of male and female condoms available | -ITNs and appropriate insecticides available for demonstration | -To extent possible, state-of-art Rx available (e.g. ventilators) for those infected and symptomatic, in gender and culturally sensitive way |
| Obligation met (yes/no, comment) | ||||
| 6. Health information and research | -Data disaggregated by sex and social determinants relevant to ZIKV widely disseminated in appropriate languages and formats | -Comprehensive information on ZIKV risks and prevention of sexual transmission widely disseminated in gender and culturally sensitive way | -Comprehensive information on ZIKV risks imparted in gender and culturally sensitive way | -Research on Rx supported, with attention to sex differences in effects |
| Obligation met (yes/no, comment) | ||||
| (b) Framework (Part 2) to assess clients’ realization of gender-related health care rights. | ||||
| Client perspective (right held) | Benchmarks | |||
| Obligations | Available | Accessible | Accessible | Quality |
| Access to discrimination-free health facilities, goods, andservices | ||||
| Access to essential drugs | ||||
| Equitable distribution of health facilities, goods, and services | ||||
Example of implementation process.
| Suggested steps | Participants/contributors |
|---|---|
| I. Obtain health system perspective | |
| 1. Select health system component(s) (e.g. hospital, clinic, specialized service) and building block(s) to be assessed | Responsible personnel or task force identified for assessment (usually concerned health officials, researcher/evaluator) |
| 2. Select health issue/condition, as relevant | Consult with biomedical specialists, concerned non-governmental organizations and civil society regarding health issue/condition and its impact |
| 3. Garner expert advice on recommended policies and best practices | WHO and/or other relevant expert organizations; gender and human rights experts |
| 4. Stakeholder consultations | Range of relevant stakeholders, including health staff, other relevant public and private sector stakeholders, and clients of all genders |
| II. Obtain client perspective | |
| 1. Stakeholder interviews and consultations | Representatives of gender and human rights groups, and civil society, preferably of different genders, roughly representative of their distribution in the service area |
| 2. Visit areas particularly affected by the weaknesses identified in the health system response | District health and local health staff, civil society representative of demographic and socioeconomic groups most affected |
| III. Analysis | |
| 1. Complete draft framework based on analysis and synthesis of findings | Responsible personnel or task force from I(1) above, with assistance from health information/research staff |
| 2. Prepare draft action plan, with built-in targets, indicators, and milestones | Responsible personnel or task force from I(1) above, and key persons responsible for eventual implementation |
| IV. Feedback to main stakeholders | |
| 1. Provide feedback and obtain comments from stakeholders | A representative selection of key stakeholders involved in previous consultations and those who will be mainly affected by/involved in proposed changes |
| 2. Share draft action plan and revise according to stakeholders’ input | As above |
| V. Implementation and monitoring of action plan | Health system representatives, clients and other stakeholders identified in Step IV above |